Sign In

Email Address:

Password:

Forgot password?

New User?

Register for Mayo Medical Laboratories

Contact Us

United States, Canada

International

Reference Laboratory Services for
Health Care Organizations

Featured Stories

MML Courier and Carrier Schedules for the Holidays December 19

MML Courier and Carrier Schedules for the HolidaysDue to the Christmas and New Year's holidays in the United States, Mayo Medical Laboratories will be adjusting its courier and carrier schedules. FedEx shipments tendered on Wednesday, Dec. 24 and Wednesday, Dec. 31 will be delivered on Friday. Mayo couriers will make pickups on Wednesdays, but the routes/times may need to be adjust to accommodate carrier schedules. Mayo couriers will not make pickups on Thursday. Normal pickups and deliveries will resume on Friday afternoon, Dec. 26 and Jan. 2.

Read this story

Evaluation of a Prolonged Activated Partial Thromboplastin Time (APTT) December 15

Evaluation of a Prolonged Activated Partial Thromboplastin Time (APTT) [Hot Topic]An activated partial thromboplastin clotting time (APTT) can be abnormal in a heterogeneous group of disorders. Risks associated with a prolonged APTT include hemorrhage or thrombosis, or the prolongation can have no hemostatic consequence. An abnormal APTT should always be evaluated within the context of the patient’s clinical history.

Read this story

Leica Biosystems and Mayo Clinic Collaborate on Future of Cytogenetics Imaging December 15

Leica Biosystems and Mayo Clinic Collaborate on Future of Cytogenetics ImagingLeica Biosystems and Mayo Clinic’s Department of Laboratory Medicine and Pathology announced today a collaboration to develop the next generation of cytogenetics imaging software.

Read this story

Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening December 8

Triple-Negative Breast Cancer Patients Should Undergo Genetic ScreeningAccording to a recent Mayo Clinic-led study, most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2. The findings come from the largest analysis to date of genetic mutations in this aggressive form of breast cancer.

Read this story


Key